Targeted therapy focuses on specific molecules involved in cancer growth. This approach can be more effective and less harmful to normal cells compared to traditional chemotherapy. Drugs like PARP inhibitors are used in ovarian cancer treatment, exploiting specific weaknesses in cancer cells.
